[1] |
Agner T, Elsner P. Hand eczema: epidemiology, prognosis and prevention[J]. J Eur Acad Dermatol Venereol, 2020,34 Suppl 1:4⁃12. doi: 10.1111/jdv.16061.
|
[2] |
Thyssen JP, Johansen JD, Linneberg A, et al. The epidemiology of hand eczema in the general population⁃⁃prevalence and main findings[J]. Contact Dermatitis, 2010,62(2):75⁃87. doi: 10. 1111/j.1600⁃0536.2009.01669.x.
|
[3] |
Furue M, Yamazaki S, Jimbow K, et al. Prevalence of dermatological disorders in Japan: a nationwide, cross⁃sectional, seasonal, multicenter, hospital⁃based study[J]. J Dermatol, 2011,38(4):310⁃320. doi: 10.1111/j.1346⁃8138.2011.01209.x.
|
[4] |
Menné T, Johansen JD, Sommerlund M, et al. Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema[J]. Contact Dermatitis, 2011,65(1):3⁃12. doi: 10.1111/j.1600⁃0536.2011.01915.x.
|
[5] |
Diepgen TL, Andersen KE, Chosidow O, et al. Guidelines for diagnosis, prevention and treatment of hand eczema[J]. J Dtsch Dermatol Ges, 2015,13(1):e1⁃e22. doi:10.1111/ddg.12510_1.
|
[6] |
Diepgen TL, Elsner P, Schliemann S, et al. Guideline on the management of hand eczema ICD⁃10 Code: L20. L23. L24. L25. L30[J]. J Dtsch Dermatol Ges, 2009,7 Suppl 3:S1⁃S16. doi: 10. 1111/j.1610⁃0387.2009.07061.x.
|
[7] |
刘岳花, 卢凤艳. 手部湿疹的病因与治疗研究现状[J]. 皮肤病与性病, 2017,39(4):261⁃263. doi: 10.3969/j.issn.1002⁃1310. 2017.04.014.
|
[8] |
余艺昕, 杨斌. 手湿疹中外诊疗指南概述[J]. 中华皮肤科杂志, 2019,52(1):53⁃56. doi: 10.3760/cma.j.issn.0412⁃4030.2019. 01.018.
|
[9] |
Park JB, Lee SH, Kim KJ, et al. Clinical features and awareness of hand eczema in Korea[J]. Ann Dermatol, 2016,28(3):335⁃343. doi: 10.5021/ad.2016.28.3.335.
|
[10] |
Angelova⁃Fischer I, Hoek AK, Dapic I, et al. Barrier function and natural moisturizing factor levels after cumulative exposure to a fruit⁃derived organic acid and a detergent: different outcomes in atopic and healthy skin and relevance for occupational contact dermatitis in the food industry[J]. Contact Dermatitis, 2015,73(6):358⁃363. doi: 10.1111/cod.12464.
|
[11] |
Bains SN, Nash P, Fonacier L. Irritant contact dermatitis[J]. Clin Rev Allergy Immunol, 2019,56(1):99⁃109. doi: 10.1007/s12016⁃018⁃8713⁃0.
|
[12] |
Visser MJ, Verberk MM, Campbell LE, et al. Filaggrin loss⁃of⁃function mutations and atopic dermatitis as risk factors for hand eczema in apprentice nurses: part II of a prospective cohort study[J]. Contact Dermatitis, 2014,70(3):139⁃150. doi: 10.1111/cod. 12139.
|
[13] |
Visser MJ, Landeck L, Campbell LE, et al. Impact of atopic dermatitis and loss⁃of⁃function mutations in the filaggrin gene on the development of occupational irritant contact dermatitis[J]. Br J Dermatol, 2013,168(2):326⁃332. doi: 10.1111/bjd.12083.
|
[14] |
Visser MJ, Verberk MM, van Dijk FJ, et al. Wet work and hand eczema in apprentice nurses; part I of a prospective cohort study[J]. Contact Dermatitis, 2014,70(1):44⁃55. doi: 10.1111/cod. 12131.
|
[15] |
Mernelius S, Carlsson E, Henricson J, et al. Staphylococcus aureus colonization related to severity of hand eczema[J]. Eur J Clin Microbiol Infect Dis, 2016,35(8):1355⁃1361. doi: 10.1007/s10096⁃016⁃2672⁃2.
|
[16] |
Jungersted JM, Høgh JK, Hellgren LI, et al. Hand eczema and stratum corneum ceramides[J]. Clin Exp Dermatol, 2015,40(3):243⁃246. doi: 10.1111/ced.12502.
|
[17] |
Coenraads PJ. Hand eczema[J]. N Engl J Med, 2012,367(19):1829⁃1837. doi: 10.1056/NEJMcp1104084.
|
[18] |
Diepgen TL, Andersen KE, Brandao FM, et al. Hand eczema classification: a cross⁃sectional, multicentre study of the aetiology and morphology of hand eczema[J]. Br J Dermatol, 2009,160(2):353⁃358. doi: 10.1111/j.1365⁃2133.2008.08907.x.
|
[19] |
Scalone L, Cortesi PA, Mantovani LG, et al. Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy[J]. Br J Dermatol, 2015,172(1):187⁃195. doi: 10.1111/bjd.13220.
|
[20] |
Lehucher⁃Michel MP, Koeppel MC, Lanteaume A, et al. Dyshidrotic eczema and occupation: a descriptive study[J]. Contact Dermatitis, 2000,43(4):200⁃205. doi: 10.1034/j.1600⁃0536.2000.043004200.x.
|
[21] |
Agner T, Aalto⁃Korte K, Andersen KE, et al. Classification of hand eczema[J]. J Eur Acad Dermatol Venereol, 2015,29(12):2417⁃2422. doi:10.1111/jdv.13308
|
[22] |
Lynde C, Guenther L, Diepgen TL, et al. Canadian hand dermatitis management guidelines[J]. J Cutan Med Surg, 2010,14(6):267⁃284. doi: 10.2310/7750.2010.09094.
|
[23] |
De Groot AC, Frosch PJ. Patch test concentrations and vehicles for testing contact allergens[M]//Johanssen JD, Frosch PJ, Lepoittevin JP. Contact dermatitis. 5th ed. Heidelberg: Springer⁃Verlag, 2011:1071⁃1105.
|
[24] |
Rietschel RL, Fowler JF. Fisher′s contact dermatitis[M]. 6th ed. Hamilton: BC Decker, 2008:743⁃808.
|
[25] |
Held E, Skoet R, Johansen JD, et al. The hand eczema severity index (HECSI): a scoring system for clinical assessment of hand eczema. A study of inter⁃ and intraobserver reliability[J]. Br J Dermatol, 2005,152(2):302⁃307. doi: 10.1111/j.1365⁃2133.2004. 06305.x.
|
[26] |
Skudlik C, Dulon M, Pohrt U, et al. Osnabrueck hand eczema severity index⁃⁃a study of the interobserver reliability of a scoring system assessing skin diseases of the hands[J]. Contact Dermatitis, 2006,55(1):42⁃47. doi: 10.1111/j.0105⁃1873.2006. 00871.x.
|
[27] |
Hald M, Agner T, Blands J, et al. Clinical severity and prognosis of hand eczema[J]. Br J Dermatol, 2009,160(6):1229⁃1236. doi: 10.1111/j.1365⁃2133.2009.09139.x.
|
[28] |
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)⁃⁃a simple practical measure for routine clinical use[J]. Clin Exp Dermatol, 1994,19(3):210⁃216. doi: 10.1111/j.1365⁃2230.1994.tb01167.x.
|
[29] |
Strauss RM, Gawkrodger DJ. Occupational contact dermatitis in nurses with hand eczema[J]. Contact Dermatitis, 2001,44(5):293⁃296. doi: 10.1034/j.1600⁃0536.2001.440508.x.
|
[30] |
Wrangsjö K, Wallenhammar LM, Ortengren U, et al. Protective gloves in Swedish dentistry: use and side⁃effects[J]. Br J Dermatol, 2001,145(1):32⁃37. doi: 10.1046/j.1365⁃2133.2001. 04278.x.
|
[31] |
Held E, Lund H, Agner T. Effect of different moisturizers on SLS⁃irritated human skin[J]. Contact Dermatitis, 2001,44(4):229⁃234. doi: 10.1034/j.1600⁃0536.2001.044004229.x.
|
[32] |
Zachariae C, Held E, Johansen JD, et al. Effect of a moisturizer on skin susceptibility to NiCl2[J]. Acta Derm Venereol, 2003,83(2):93⁃97. doi: 10.1080/00015550310007418.
|
[33] |
张建中. 糖皮质激素皮肤科规范应用手册[M]. 上海: 上海科学技术出版社, 2011.
|
[34] |
Chong M, Fonacier L. Treatment of eczema: corticosteroids and beyond[J]. Clin Rev Allergy Immunol, 2016,51(3):249⁃262. doi: 10.1007/s12016⁃015⁃8486⁃7.
|
[35] |
González⁃López G, Ceballos⁃Rodríguez RM, González⁃López JJ, et al. Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta⁃analysis[J]. Br J Dermatol, 2017,177(3):688⁃695. doi: 10.1111/bjd.15165.
|
[36] |
Elsner P, Agner T. Hand eczema: treatment[J]. J Eur Acad Dermatol Venereol, 2020,34 Suppl 1:13⁃21. doi: 10.1111/jdv. 16062.
|
[37] |
Brass D, Fouweather T, Stocken DD, et al. An observer⁃blinded randomized controlled pilot trial comparing localized immersion psoralen⁃ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema[J]. Br J Dermatol, 2018,179(1):63⁃71. doi: 10.1111/bjd.16238.
|
[38] |
Ling TC, Clayton TH, Crawley J, et al. British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen⁃ultraviolet A therapy 2015[J]. Br J Dermatol, 2016,174(1):24⁃55. doi: 10.1111/bjd. 14317.
|
[39] |
Sheehan⁃Dare RA, Goodfield MJ, Rowell NR. Topical psoralen photochemotherapy (PUVA) and superficial radiotherapy in the treatment of chronic hand eczema[J]. Br J Dermatol, 1989,121(1):65⁃69. doi: 10.1111/j.1365⁃2133.1989.tb01401.x.
|
[40] |
Jankowska⁃Konsur A, Reich A, Szepietowski JC. Systemic antihistamines⁃⁃a common outside the guidelines therapeutic strategy in hand eczema management[J]. J Eur Acad Dermatol Venereol, 2016,30(1):67⁃71. doi: 10.1111/jdv.13060.
|
[41] |
Politiek K, van der Schaft J, Christoffers WA, et al. Drug survival of methotrexate treatment in hand eczema patients: results from a retrospective daily practice study[J]. J Eur Acad Dermatol Venereol, 2016,30(8):1405⁃1407. doi: 10.1111/jdv. 13253.
|
[42] |
Navarro⁃Triviño FJ, Cuenca⁃Barrales C, Vega⁃Castillo JJ, et al. Chronic hand eczema and hepatogenic pruritus with good response to apremilast[J]. Dermatol Ther, 2019,32(3):e12879. doi: 10.1111/dth.12879.
|
[43] |
Chipalkatti N, Lee N, Zancanaro P, et al. Dupilumab as a treatment for allergic contact dermatitis[J]. Dermatitis, 2018,29(6):347⁃348. doi: 10.1097/DER.0000000000000414.
|
[44] |
Zirwas MJ. Dupilumab for hand eczema[J]. J Am Acad Dermatol, 2018,79(1):167⁃169. doi: 10.1016/j.jaad.2018.02.073.
|
[45] |
Tauscher AE, Fleischer AB Jr, Phelps KC, et al. Psoriasis and pregnancy[J]. J Cutan Med Surg, 2002,6(6):561⁃570. doi: 10. 1007/s10227⁃001⁃0147⁃1.
|
[46] |
Hoffman MB, Farhangian M, Feldman SR. Psoriasis during pregnancy: characteristics and important management recommendations[J]. Expert Rev Clin Immunol, 2015,11(6):709⁃720. doi: 10.1586/1744666X.2015.1037742.
|
[47] |
Sigurgeirsson B, Boznanski A, Todd G, et al. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5⁃year randomized trial[J]. Pediatrics, 2015,135(4):597⁃606. doi: 10.1542/peds.2014⁃1990.
|
[48] |
Margolis DJ, Abuabara K, Hoffstad OJ, et al. Association between malignancy and topical use of pimecrolimus[J]. JAMA Dermatol, 2015,151(6):594⁃599. doi: 10.1001/jamadermatol. 2014.4305.
|